Is a Stem-Cell Transplant Needed?
- AML patients who are considered “intermediate risk” may need allogeneic stem-cell transplant, but in all cases
- Whether the transplant is given depends on how well the patient responds to standard chemotherapy as well as how much disease is still detectable in your body
RELATED: What Should AML Patients Expect During a Bone Marrow Transplant?
Read More“This is how we now define remission. If you have minimal residual disease … intermediate risk disease sometimes can be good if you respond to the standard chemotherapy, then you don’t need transplantation — and you have a good outcome,” Dr. Yaghmour says.
Learn more about SurvivorNet's rigorous medical review process.
